https://npcr.se/nyhet/2013-05-30T08:13:42+02:00https://npcr.se/ny-studie-publicerad/2013-06-19T08:54:29+02:00https://npcr.se/ny-studie-skelettscintigrafi/2013-09-04T13:35:33+02:00https://npcr.se/artikel-som-beskriver-sams/2013-09-09T09:28:31+02:00https://npcr.se/10-procent-av-man-som-genomgatt-radikal-prostatektomi-aterinlaggs-pa-sjukhus-det-visar-en-undersokning-i-npcr-aterinlaggningsfrekvensen-var-lika-hog-efter-robot-assisterad-laparoskopisk-operation-oc/2014-02-17T15:37:54+01:00https://npcr.se/npcr-startar-register-for-radikal-prostatektomi/2014-02-19T13:11:18+01:00https://npcr.se/en-inflation-av-gleasongraderingen-dvs-den-mikroskopiska-bedomningen-av-prostatacancer-har-skett-visar-en-undersokning-i-npcr-forandringen-har-varity-gradvis-och-blivit-tydliga/2014-02-25T12:23:55+01:00https://npcr.se/psa-testning-och-tidig-behandling-minskar-dodligheten-i-prostatacancer/2014-03-12T13:27:21+01:00https://npcr.se/forfinad-gradering-av-prostatacancer-nodvandig/2014-03-14T14:01:48+01:00https://npcr.se/socioekonomiska-skillnader-i-anvandningen-av-potenslakemedel-efter-behandling-for-prostatacancer/2014-06-17T13:27:30+02:00https://npcr.se/aktiv-monitorering-vid-prostatacancer-av-lagrisktyp-allt-vanligare/2014-07-08T11:30:32+02:00https://npcr.se/forfinade-kriterier-for-aktiv-monitorering-av-prostatacancer/2014-08-18T17:46:11+02:00https://npcr.se/informationen-i-prostatacancerregistret-ar-representativ-for-alla-man-med-prostatacancer-i-sverige/2014-08-18T17:37:28+02:00https://npcr.se/data-i-npcr-haller-hog-kvalite/2014-12-22T15:45:26+01:00https://npcr.se/overvikt-fysisk-aktivitet-och-risk-for-prostatacancer-och-prostatacancerdod/2015-01-27T15:01:53+01:00https://npcr.se/psa-test-identifierar-grupper-med-hog-och-lag-risk-for-metastaserad-prostatacancer/2015-02-20T10:55:42+01:00https://npcr.se/hormonbehandling-av-prostatacancer-och-hjartsjukdom/2015-03-06T09:25:59+01:00https://npcr.se/manga-aldre-man-med-allvarlig-prostatacancer-underbehandlas-med-stora-regionala-skillnader/2015-04-01T16:46:19+02:00https://npcr.se/langtidsuppfoljning-av-symtom-bland-man-med-lokaliserad-prostatacancer/2015-06-01T09:10:20+02:00https://npcr.se/impotensmedel-okar-inte-risk-for-melanom/2015-07-09T15:02:29+02:00https://npcr.se/somn-och-prostatacancer/2015-06-30T11:24:16+02:00https://npcr.se/finasterid-och-dutasterid-okar-inte-risken-for-manlig-brostcancer/2015-07-09T15:08:53+02:00https://npcr.se/psa-over-100-ar-inte-lika-med-skelettmetastaser/2015-08-12T12:15:40+02:00https://npcr.se/koll-pa-laget-fran-npcr-rapporterad-internationellt/2015-08-12T12:17:10+02:00https://npcr.se/risk-for-blodpropp-hos-man-med-hormonbehandlad-prostatacancer/2015-10-30T08:52:15+01:00https://npcr.se/melanom-och-prostatacancer-inget-orsaksamband/2015-12-23T12:27:42+01:00https://npcr.se/npcr-publicerar-metodarbete/2015-12-23T12:26:50+01:00https://npcr.se/vardering-av-ny-gleasongradering-i-npcr/2015-12-30T14:26:48+01:00https://npcr.se/fosfodiesterashammare-och-aterfall-av-prostatacancer-efter-operation-falskt-alarm/2016-01-12T12:33:39+01:00https://npcr.se/lag-dodlighet-efter-radikal-prostatektomi-visar-studie-i-npcr/2016-01-18T15:29:43+01:00https://npcr.se/lika-manga-sjukdagar-pa-lang-sikt-efter-oppen-och-robot-assisterad-prostatektomi/2016-01-21T11:40:14+01:00https://npcr.se/liten-risk-for-tarmvred-efter-prostatektomi-visar-studie-fran-npcr/2016-03-10T12:39:43+01:00https://npcr.se/okad-overensstammelse-i-gleasonsumma-mellan-prostatabiopsi-och-preparat-fran-prostatektomi/2016-03-11T11:02:37+01:00https://npcr.se/prostatektomi-efter-aktiv-monitorering/2016-04-15T14:46:36+02:00https://npcr.se/npcr-slar-hal-pa-falska-larm/2016-04-27T08:56:54+02:00https://npcr.se/komplikationer-efter-kurativ-stralbehandling-och-radikal-prostatektomi/2016-07-05T12:05:07+02:00https://npcr.se/man-under-50-ars-alder-med-spridd-prostatacancer-har-samre-prognos-an-aldre-man/2016-07-05T12:04:29+02:00https://npcr.se/arftlighet-och-risk-for-prostatacancer-uppdelad-pa-sjukdomens-allvarlighetsgrad/2016-10-20T11:42:14+02:00https://npcr.se/var-gar-gransen-for-nyttan-av-lokalbehandling-av-prostatacancer/2016-10-20T11:59:56+02:00https://npcr.se/battre-prognos-med-ny-gleasonklassifikation/2016-08-22T12:40:35+02:00https://npcr.se/okar-snus-risken-for-progress-av-prostatacancer/2016-09-07T14:40:25+02:00https://npcr.se/risk-for-diabetes-bland-man-som-hormonbehandlas-for-prostatacancer/2016-09-07T14:39:31+02:00https://npcr.se/lag-andel-av-man-med-okand-riskkategori-i-npcr/2016-10-20T12:22:03+02:00https://npcr.se/aktiv-monitorering-anvands-for-allt-fler-man-med-lagriskcancer/2016-10-25T15:14:04+02:00https://npcr.se/minskad-risk-for-prostatacancer-bland-man-med-typ-2-diabetes/2016-10-26T12:12:22+02:00https://npcr.se/overgangen-fran-aktiv-monitorering-till-watchful-waiting-studerad-for-forsta-gangen/2016-11-09T13:06:44+01:00https://npcr.se/testosteronbehandling-okar-inte-risken-for-aggressiv-prostatacancer/2017-05-04T15:19:57+02:00https://npcr.se/langa-vantetider-inom-cancervarden-och-allra-langst-for-man-med-prostatacancer/2017-05-04T15:31:15+02:00https://npcr.se/alltfor-sallan-kurativ-behandling-av-prostatacancer-bland-man-med-diabetes/2017-05-05T15:54:09+02:00https://npcr.se/ingen-okad-risk-for-trombos-eller-lungemboli-for-man-som-stralbehandlas-for-prostatacancer/2017-05-12T14:32:01+02:00https://npcr.se/synergi-mellan-antiandrogen-och-vitamin-k-antagonist-vid-prostatatacancer/2017-06-15T10:54:30+02:00https://npcr.se/komplikationer-efter-robotassisterad-och-oppen-radikal-prostatektomi/2017-07-14T14:23:09+02:00https://npcr.se/bara-10-av-oppna-operatorer-och-50-av-robot-operatorer-gor-mer-an-25-radikala-prostatektomier-om-aret/2017-09-18T15:45:21+02:00https://npcr.se/urininkontinens-efter-radikal-prostatektomi-kartlagd/2017-09-11T12:01:40+02:00https://npcr.se/ingen-skillnad-i-risk-for-hjartkarlsjukdom-efter-kirurgisk-och-medicinsk-kastration/2017-09-15T12:44:38+02:00https://npcr.se/prognosen-for-man-med-prostatacancer-stadium-pt3b-ar-fortsatt-dalig-jamfort-med-pt3a-men-fa-patienter-med-lokalt-avancerad-sjukdom-dor-inom-sex-ar-efter-prostatektomi/2017-10-19T14:29:39+02:00https://npcr.se/operation-och-stralterapi-ar-likvardiga-behandlingar-for-prostatacancer/2018-01-25T11:13:52+01:00https://npcr.se/gamla-och-ensamstaende-man-far-mindre-smartlindring-vid-terminal-prostatacancer/2018-01-25T11:13:20+01:00https://npcr.se/socioekonomiska-skillnader-i-prostatacancervard/2018-02-06T12:22:50+01:00https://npcr.se/stora-geografiska-skillnader-i-tillgang-till-behandling-for-spridd-prostatacancer/2018-02-06T14:27:24+01:00https://npcr.se/data-i-npcr-bekraftar-vardet-av-cambridge-prognostic-groups-for-man-med-prostatacancer/2018-03-12T16:28:05+01:00https://npcr.se/data-i-nationella-prostatacancerregistret-haller-hog-kvalitet/2018-03-16T16:28:48+01:00https://npcr.se/ingen-okad-risk-for-prostatacancer-for-man-som-haft-urinvagsinfektion/2018-04-20T15:29:34+02:00https://npcr.se/okad-risk-for-behandlingskravande-icke-lagrisk-prostatacancer-bland-man-med-broder-med-prostatacancer/2018-04-25T16:25:16+02:00https://npcr.se/skillnader-i-risken-for-prostatacancer/2018-06-04T13:37:42+02:00https://npcr.se/dod-efter-prostatektomi-en-jamforelse-mellan-spcg-4-och-nutida-resultat-i-npcr/2018-10-14T21:03:00+02:00https://npcr.se/foljsamhet-till-riktlinjer-for-prostatacancersjukvard/2018-11-26T09:30:00+01:00https://npcr.se/bikalutamid-likvardigt-med-gnrh-agonist-som-behandling-av-avancerad-icke-metastaserad-prostatacancer/2018-11-28T09:12:45+01:00https://npcr.se/mindre-forandring-av-samsjuklighet-bland-man-behandlade-med-antiandrogen-jamfort-med-gnrh-agonister/2018-12-11T10:25:01+01:00https://npcr.se/operation-for-rektalcancer-efter-stralbehandling-av-prostatacancer/2018-12-13T18:58:33+01:00https://npcr.se/hormonbehandling-och-risk-for-demens/2019-01-24T17:47:34+01:00https://npcr.se/tva-filmer-om-npcr/2019-03-29T17:44:28+01:00https://npcr.se/sammanfattning-om-struktur-och-anvandning-av-data-i-npcr/2019-04-17T13:18:46+02:00https://npcr.se/prediktion-av-langa-sjukdomforlopp-med-hjalp-av-data-i-pcbase/2019-06-14T12:55:35+02:00https://npcr.se/ett-nytt-satt-att-undersoka-risken-for-prostatacancerdod/2019-06-25T14:15:35+02:00https://npcr.se/matning-av-dna-och-rna-i-formalinfixerade-prostatabiopsier/2019-06-25T14:28:27+02:00https://npcr.se/registrering-av-prostatektomier-i-sverige-pis/2019-08-20T19:21:24+02:00https://npcr.se/artikel-om-npcr-publicerad-i-research-outreach/2019-08-22T14:46:34+02:00https://npcr.se/langsiktigt-forbattringsarbete-pa-sahlgrenska-ger-resultat/2019-09-16T11:24:20+02:00https://npcr.se/forbattrad-overlevnad-for-man-med-metastaserad-prostatacancer-visar-studie-i-npcr/2019-09-23T12:09:00+02:00https://npcr.se/smartlindring-med-opiater-skots-val-i-sverige/2019-10-07T18:44:27+02:00https://npcr.se/vilket-verktyg-ar-bast-for-riskgruppering/2019-10-15T09:05:16+02:00https://npcr.se/nytt-nomogram-kan-bespara-en-stor-andel-man-med-nydiagnostiserad-prostatacancer-onodiga-undersokningar/2019-12-19T14:36:57+01:00https://npcr.se/gnrh-preparat-med-langa-injektionsintervall-kan-oka-andelen-man-som-fortsatter-sin-hormonbehandling/2020-01-09T10:48:49+01:00https://npcr.se/lakarens-rekommendation-av-behandling-vager-tungt/2020-01-10T11:29:28+01:00https://npcr.se/ingen-okad-risk-for-prostatacancer-bland-man-som-genomgatt-njurtransplantation/2020-02-10T13:04:56+01:00https://npcr.se/man-med-lagriskcancer-kan-foljas-med-aktiv-monitorering-aven-om-de-har-slaktingar-med-prostatacancer/2020-03-18T16:44:36+01:00https://npcr.se/nar-kan-man-lata-bli-att-gora-skelettundersokning-vid-avancerad-prostatacancer/2020-02-19T08:54:46+01:00https://npcr.se/stralbehandling-av-prostatacancer-i-sverige-1998-2016/2020-03-04T14:19:10+01:00https://npcr.se/blodtrycksmedicinen-spironolakton-minskade-risken-for-prostatacancer/2020-07-15T09:07:20+02:00https://npcr.se/fa-sjukskrivningsdagar-bland-man-som-foljs-med-aktiv-monitorering/2020-07-15T09:07:19+02:00https://npcr.se/lokalt-avancerad-prostatacancer-allt-fler-man-med-behandlas-och-allt-farre-man-dor/2020-04-17T14:51:53+02:00https://npcr.se/5-alfareduktashammare-och-gleasongradering/2020-04-22T13:26:54+02:00https://npcr.se/overlevnad-efter-stralterapi/2020-05-08T08:51:43+02:00https://npcr.se/diabetesmediciner-och-risk-for-prostatacancer/2020-06-18T15:36:39+02:00https://npcr.se/vanligt-med-for-tidig-hormonterapi-efter-radikal-prostatektomi/2020-06-22T09:23:32+02:00https://npcr.se/overviktiga-man-har-okad-risk-att-do-av-prostatacancer/2020-07-03T17:18:57+02:00https://npcr.se/langre-overlevnad-for-man-med-kastrationsresistent-prostatacancer/2020-07-15T08:59:07+02:00https://npcr.se/antibiotikaanvandning-i-samband-med-prostatabiopsier-kartlagt-i-studie/2020-07-22T10:56:38+02:00https://npcr.se/predict-prostate-ett-verktyg-for-individuell-sjukdomsprognos/2020-07-29T18:22:47+02:00https://npcr.se/blodfortunnande-mediciner-och-risk-for-prostatacancer/2020-11-15T17:42:59+01:00https://npcr.se/uttagna-recept-och-overlevnad/2020-11-20T20:53:14+01:00https://npcr.se/simuleringsmodell-undersoker-risk-for-prostatacancer/2020-11-26T23:48:45+01:00https://npcr.se/snabb-uppfoljning-av-anvandning-av-abirateron-vid-nydiagnostiserad-metastaserad-prostatacancer-med-hjalp-av-kvalitets-och-halsodataregister/2020-12-12T15:47:56+01:00https://npcr.se/tid-i-olika-sjukdomsstadier-for-man-med-avancerad-prostatacancer/2020-12-15T18:14:50+01:00https://npcr.se/adekvat-behandlingstid-med-abirateron-och-enzalutamid-visar-studie-i-npcr/2021-01-06T16:01:09+01:00https://npcr.se/innebar-kombinationsbehandling-for-prostatacancer-en-okad-risk-for-hjart-karlsjukdomar/2021-03-04T14:41:29+01:00https://npcr.se/real-world-data-i-svenska-kvalitetsregister-en-ovarderlig-kunskapskalla-for-forskning-och-utveckling/2021-04-13T10:01:43+02:00https://npcr.se/svensk-sjukvard-prioriterade-behandling-av-prostatacancerpatienter-under-pandemin/2021-05-03T13:26:01+02:00https://npcr.se/kortvarig-kur-med-ciprofloxacin-okar-inte-risken-for-aortaaneurysm/2021-05-03T15:05:51+02:00https://npcr.se/ny-metod-forbattrar-mojligheten-att-forutsaga-overlevnad-vid-cancer/2021-05-27T08:23:13+02:00https://npcr.se/mr-forst-hur-gar-det/2021-05-24T09:51:57+02:00https://npcr.se/kunskap-om-metoder-avgorande-nar-dodsorsak-undersoks-bland-aldre-man-med-prostatacancer/2021-05-25T08:11:57+02:00https://npcr.se/ipo-individuell-patientoversikt-vinner-terrang/2021-05-27T15:10:12+02:00https://npcr.se/lag-dodlighet-efter-radikal-prostatektomi-visar-npcr-studie/2021-07-19T11:34:50+02:00https://npcr.se/nytt-samsjuklighetsindex-ger-prognos-for-man-med-kastrationsresistent-prostatacancer/2021-08-16T17:49:13+02:00https://npcr.se/psa-driven-diagnostik-har-raddat-liv-men-till-ett-hogt-pris/2021-08-22T14:38:38+02:00https://npcr.se/hog-kirurgisk-volym-ger-battre-kvalitet-och-farre-komplikationer/2021-08-23T14:19:58+02:00https://npcr.se/saker-lakemedelsanvandning-vid-avancerad-prostatacancer/2021-09-21T15:35:31+02:00https://npcr.se/hormonbehandling-vid-prostatacancer-skyddar-inte-mot-covid-19/2021-10-08T11:38:32+02:00https://npcr.se/varfor-ar-behandlingstiden-med-abirateron-mycket-kortare-i-sjukvarden-an-i-kliniska-provningar/2022-01-13T13:54:14+01:00https://npcr.se/hormonbehandling-skyddar-inte-mot-svar-covid-infektion-och-dod-hos-man-med-prostatacancer/2022-01-17T15:04:23+01:00https://npcr.se/langvarig-hormonbehandling-okar-risken-for-ljumskbrack/2022-01-24T16:15:56+01:00https://npcr.se/patientoversikten-ger-stora-tidsvinster-jamfort-med-elektroniska-journaler/2022-02-03T11:20:45+01:00https://npcr.se/3964-2/2022-02-16T11:16:41+01:00https://npcr.se/hogt-blodtryck-ar-ingen-riskfaktor-for-prostatacancer/2022-05-17T12:55:30+02:00https://npcr.se/rokning-kan-oka-risken-for-dod-i-prostatacancer/2022-05-18T12:52:28+02:00https://npcr.se/man-opererade-och-sedan-stralbehandlade-for-prostatacancer-har-mer-besvar-fran-urinvagarna-an-man-som-bara-ar-opererade/2022-06-09T16:19:26+02:00https://npcr.se/nytt-verktyg-kan-forutsaga-prognosen-for-man-med-icke-metastaserad-prostatacancer/2022-06-13T17:21:01+02:00https://npcr.se/trender-i-prostatacancerdodlighet-avhandling-baserad-pa-data-i-npcr/2022-06-13T17:28:34+02:00https://npcr.se/man-med-prostatacancer-har-50-procents-okad-risk-for-blodproppar/2022-06-15T15:24:20+02:00https://npcr.se/prostatacancerincidens-behandling-och-dodlighet-ytterligare-en-avhandling-baserad-pa-data-i-npcr/2022-08-18T10:50:05+02:00https://npcr.se/antiandrogen-behandling-skyddar-inte-mot-svar-covid-infektion-och-dod-hos-man-med-prostatacancer/2022-08-25T09:21:48+02:00https://npcr.se/datortomografi-buk-rekommenderas-inte-langre-for-alla-man-med-hogrisk-prostatacancer/2022-08-15T17:54:51+02:00https://npcr.se/man-med-dodlig-prostatacancer-lever-langre-och-har-en-hogre-alder-vid-dod-idag-jamfort-med-for-20-ar-sedan/2022-08-22T17:39:50+02:00https://npcr.se/urinlackage-efter-radikal-prostatektomi/2022-09-07T17:40:17+02:00https://npcr.se/bevis-for-progress-av-prostatacancer-saknas-ofta-bland-gamla-man-och-man-med-lagriskcancer-som-dog-av-prostatacancer-enligt-dodsorsaksregistret/2022-09-12T16:54:29+02:00https://npcr.se/langtidsprognos-for-man-som-behandlas-med-aktiv-monitorering-i-sverige/2022-09-15T11:33:23+02:00https://npcr.se/behandling-med-gnrh-okar-riskpoang-for-hjart-karlsjukdom-bland-man-med-diabetes-typ-2/2022-09-20T14:47:41+02:00https://npcr.se/ingen-betydelsefull-overrisk-for-frakturer-hos-man-med-kastrationsresistent-prostatacancer-behandlade-med-ra-223/2022-10-03T15:14:50+02:00https://npcr.se/stor-variation-i-prognos-och-dodlighet-bland-man-med-kastrationsresistent-prostatacancer/2022-10-13T08:50:51+02:00https://npcr.se/livsrisk-for-prostatacancer-paverkas-av-bade-diagnostisk-aktivitet-och-forvantad-livslangd/2022-12-05T14:20:23+01:00https://npcr.se/4301-2/2022-12-21T13:26:33+01:00https://npcr.se/behandling-med-gnrh-okar-risk-for-onormala-blodfetter-hos-man-med-prostatacancer-och-typ-2-diabetes/2023-01-03T10:43:49+01:00https://npcr.se/forbattringar-i-behandling-och-overlevnad-hos-man-med-spridd-prostatacancer/2023-10-10T14:23:13+02:00https://npcr.se/battre-diagnostik-med-mr-fore-biopsi-hos-man-med-forhojt-psa-en-populationsbaserad-studie/2023-11-03T12:24:41+01:00https://npcr.se/nyhetsbrev-ipo-nr-4-2023/2024-01-08T11:49:24+01:00https://npcr.se/sista-inrapporteringsdag-till-kvalitetsregistret/2024-01-23T15:49:45+01:00https://npcr.se/nu-finns-npcr-med-i-rut-metadatakatalog/2024-01-25T14:59:22+01:00https://npcr.se/nu-har-boken-bra-att-veta-om-prostatacancer-och-en-chatbot-lanserats-av-prostatacancerforbundet/2024-01-30T15:50:50+01:00https://npcr.se/har-kan-du-se-filmen-om-region-kronobergs-framgangsresa-med-kvalitetsregister-och-ipo-dar-medicinska-sekreterarna-tog-rodret/2024-02-12T15:46:47+01:00https://npcr.se/integrerad-diagnostik-i-praktiken-pilottest-i-helsingborg-med-varldsunik-losning-for-prostatacancerutredning/2024-02-27T12:01:00+01:00https://npcr.se/sammanfattning-av-arbetet-i-ipo-2023/2024-03-01T07:57:08+01:00https://npcr.se/onkologidagarna-i-malmo-19-21-mars-2024/2024-03-26T14:23:57+01:00https://npcr.se/npcr-har-rekryterat-en-ny-ordforande-for-styrgruppen-och-arbetsgruppsledare-for-ipo/2024-04-02T10:17:31+02:00https://npcr.se/arets-forsta-nyhetsbrev-ipo-med-releasenoteringar-for-version-12-0/2024-05-02T08:15:30+02:00https://npcr.se/ny-studie-om-orsaker-till-overgang-fran-aktiv-monitorering-till-behandling/2024-05-07T12:01:54+02:00https://npcr.se/sjukdomsforlopp-for-hogrisk-och-lokalt-avancerad-prostatacancer-kartlagda-i-ny-studie/2024-06-05T13:52:21+02:00https://npcr.se/risken-for-dod-i-prostatacancer-hos-man-diagnostiserade-med-prostatacancer-vid-cystoprostatektomi/2024-06-14T12:40:05+02:00https://npcr.se/npcrs-registersjukskoterska-maria-nyberg-gar-i-pension-och-nu-soker-vi-en-ny-registersamordnare/2024-06-25T09:29:16+02:00https://npcr.se/naturalforlopp-for-icke-metastaserad-prostatacancer-handlagd-med-aktiv-monitorering/2024-08-26T17:40:54+02:00https://npcr.se/forandrade-utskick-av-patientenkater-prom-i-npcr/2024-08-26T18:01:21+02:00https://npcr.se/webbinarium-om-kontaksjukskoterskans-och-patientens-nytta-av-ipo/2024-08-30T14:49:52+02:00https://npcr.se/hostens-nyhetsbrev-for-ipo-prostatacancer/2024-09-23T13:24:18+02:00https://npcr.se/forskning-pa-data-fran-npcr/2024-10-29T13:53:02+01:00https://npcr.se/banbrytande-framsteg-i-prostatacancerdiagnostik-ny-artikel-publicerad-i-british-journal-of-urology-international/2024-11-18T15:57:53+01:00https://npcr.se/ny-podcast-fatta-forskning-upptack-ais-roll-i-tidig-diagnos-av-prostatacancer/2024-11-26T15:46:01+01:00https://npcr.se/arets-sista-nyhetsbrev-for-ipo-och-rccs-npcrs-kunskapsstod/2024-12-02T17:03:39+01:00https://npcr.se/las-den-nyligen-publicerade-artikeln-i-svensk-urologi-nr-4-om-npcrs-strukturerade-diagnostikmallar/2024-12-06T14:17:10+01:00https://npcr.se/ny-enkat-till-patienter-vars-prostatabiopsier-registreras-i-realtid-i-ipo-eller-i-diagnostikmallen-biopsi/2025-01-09T17:11:13+01:00https://npcr.se/therese-knobloch-tar-over-som-ny-registersamordnare-efter-maria-nyberg/2025-01-20T11:15:05+01:00https://npcr.se/dubbel-trippelterapi-vid-metastaserad-prostatacancer-ny-rapport-pa-ratten/2025-01-23T11:05:05+01:00https://npcr.se/npcr-inleder-aret-med-styrgruppsmote-i-stockholm-30-31-januari/2025-02-11T09:28:56+01:00https://npcr.se/succe-for-ipo-pa-onkologidagarna-i-sundsvall-18-20-mars-2025/2025-03-25T11:22:18+01:00https://npcr.se/nyhetsbrev-senaste-nytt-fran-npcr/2025-04-04T16:21:28+02:00https://npcr.se/en-tredjedel-av-mannen-upplever-psa-persistens-eller-aterfall-inom-10-ar-efter-radikal-prostatektomi/2025-04-07T15:53:41+02:00https://npcr.se/gleasonpoang-mer-prognostiskt-an-gradgrupper/2025-04-14T09:23:32+02:00https://npcr.se/funktionella-resultat-av-robotassisterad-radikal-prostatektomi-efter-en-period-av-aktiv-monitorering/2025-04-15T11:21:20+02:00https://npcr.se/forbattrad-foljsamhet-till-prostatacancerriktlinjer-i-sverige-mellan-2010-och-2023/2025-04-22T09:37:04+02:00https://npcr.se/andrad-plats-och-tid-for-inrapportorsmote-onkologi/2025-04-22T13:49:52+02:00https://npcr.se/urininkontinens-efter-radikal-prostatektomi-vanligare-bland-man-med-hog-alder-stor-prostata-och-bland-de-som-inte-fatt-nervsparande-kirurgi/2025-05-06T08:48:22+02:00https://npcr.se/mindre-overbehandling-av-man-med-prostatacancer-i-sverige-jamfort-med-i-usa/2025-05-06T17:29:25+02:00https://npcr.se/hormonbehandling-for-prostatacancer-kopplat-till-risk-for-alzheimers-sjukdom-och-vaskular-demens/2025-05-16T13:14:19+02:00https://npcr.se/socioekonomiska-skillnader-i-prostatacancerupptackt/2025-05-20T14:24:59+02:00https://npcr.se/prostatacancer-i-sverige-fore-under-och-efter-covid-19/2025-05-20T14:42:49+02:00https://npcr.se/nya-samsjuklighetmatt-och-ny-metod-for-att-uppskatta-aterstaende-livslangd-hos-man-med-prostatacancer-battre-an-tidigare-metoder/2025-06-04T17:44:30+02:00https://npcr.se/nyhet-om-patientenkater-utvecklat-i-den-nationella-arbetsgruppen-for-prom-i-npcr/2025-06-10T09:11:00+02:00https://npcr.se/god-prognos-for-man-med-prostatacancer-som-behandlas-enligt-riktlinjer/2025-07-12T08:44:43+02:00https://npcr.se/svenska-risknomogram-for-prostatacancersdod-efter-operation/2025-07-24T12:15:48+02:00https://npcr.se/risknomogram-for-radikal-prostatektomi/2025-08-26T09:42:03+02:00https://npcr.se/forhojd-risk-for-urinvagshandelser-efter-stralbehandling-vid-prostatacancer-hos-man-med-hogt-ipss/2025-09-15T13:23:00+02:00https://npcr.se/okad-risk-for-tidig-och-aggressiv-prostatacancer-hos-soner-vars-fader-fatt-en-tidig-eller-aggressiv-prostatacancer/2025-09-15T13:50:58+02:00https://npcr.se/potentiella-vinster-med-radikal-behandling-av-man-med-prostatacancer-baserat-pa-forvantad-livslangd/2025-09-16T10:28:17+02:00https://npcr.se/forsta-digitala-styrgruppsmotet-efter-pandemin/2025-09-24T09:13:06+02:00https://npcr.se/npcr-deltog-pa-urologiveckan-2025-i-stockholm/2025-10-15T11:10:50+02:00https://npcr.se/gemensamt-mote-for-inrapportorer-i-urologi-och-onkologi-2026/2025-11-28T10:26:20+01:00https://npcr.se/pcbase-xtend-ny-databas-for-forskning-om-screening-och-uppfoljning-av-prostatacancer/2025-10-16T17:44:33+02:00https://npcr.se/radium-223-vid-avancerad-prostatacancer-nar-i-behandlingsforloppet-ger-det-bast-effekt/2025-10-20T15:58:56+02:00https://npcr.se/jamforbar-risk-for-risk-for-allvarliga-biverkningar-efter-ultrahypofraktionerad-radioterapi-och-konventionell-stralbehandling-av-prostatacancer/2026-06-17T00:55:59+02:00https://npcr.se/alder-och-nya-samsjuklighetsmatt-kan-agera-proxy-for-funktionsniva-i-registerbaserad-forskning/2026-06-17T01:02:08+02:00https://npcr.se/langre-overlevnad-efter-ryggkirurgi-for-metastaser-hos-man-med-kastrationskanslig-jamfort-med-kastrationsresistent-prostatacancer/2026-06-17T01:06:29+02:00https://npcr.se/tid-till-psa-aterfall-och-gleason-paverkar-gradvis-risken-for-prostatacancerdod-efter-stralbehandling/2026-06-17T01:10:08+02:00https://npcr.se/viktokning-i-senare-vuxenliv-kopplad-till-okad-risk-for-prostatacancerdod/2026-06-17T01:13:10+02:00https://npcr.se/strikta-och-mindre-strikta-psa-kriterier-for-sjukdomsprogression-under-hormonbehandling-gav-sma-skillnader-i-uppskattad-dodlighet-och-behandlingsfrekvens/2026-06-17T01:19:40+02:00